+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Prostate Cancer Diagnostics"

Prostate Cancer Diagnostics Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030 - Product Thumbnail Image

Prostate Cancer Diagnostics Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030

  • Report
  • October 2023
  • 146 Pages
  • Global
From
Prostate Cancer Diagnostics and Minimally Invasive Treatments Market: US, 5EU Markets, Japan and RoW - Product Thumbnail Image

Prostate Cancer Diagnostics and Minimally Invasive Treatments Market: US, 5EU Markets, Japan and RoW

  • Report
  • July 2019
  • Japan, United States Japan, United States
Exosome Diagnostic and Therapeutic Market By Application (Diagnostic, Therapeutic), By Product (Instrument, Reagent, Software), By End User (Cancer Institute, Hospital, Diagnostic Center, Others): Global Opportunity Analysis and Industry Forecast, 2021-2030 - Product Thumbnail Image

Exosome Diagnostic and Therapeutic Market By Application (Diagnostic, Therapeutic), By Product (Instrument, Reagent, Software), By End User (Cancer Institute, Hospital, Diagnostic Center, Others): Global Opportunity Analysis and Industry Forecast, 2021-2030

  • Report
  • August 2023
  • 110 Pages
  • Global
From
Loading Indicator

The Prostate Cancer Diagnostics market is a segment of the Diagnostics industry that focuses on the detection and diagnosis of prostate cancer. Diagnostic tests for prostate cancer include digital rectal exams, prostate-specific antigen (PSA) tests, and biopsies. These tests are used to detect the presence of cancer, as well as to monitor the progression of the disease. In recent years, advances in technology have enabled the development of more accurate and reliable diagnostic tests for prostate cancer. These tests have improved the accuracy of diagnosis and have enabled earlier detection of the disease. Additionally, the development of new treatments for prostate cancer has increased the demand for diagnostic tests. The Prostate Cancer Diagnostics market is highly competitive, with a number of companies offering a range of diagnostic tests. Some of the major players in the market include Abbott Laboratories, Becton Dickinson, Siemens Healthineers, and Roche Diagnostics. Show Less Read more